⚠ Evidence warning: Clinical trials or other evidence do not support the claim that standardized capsules are the practical option for clinical use. This page keeps it as a report of what people, websites or other media say.
Bitter Melon (Momordica charantia)
Table of Contents
Traditional Use Across Asia and the Caribbean
Bitter melon (also called bitter gourd, karela in Hindi, kŭgua in Chinese) is a tropical vine in the cucumber family whose intensely bitter, warty fruit has been eaten as both food and medicine for centuries. Genetic studies trace the wild plant to Africa, with domestication in Asia, and it became deeply established in Ayurvedic, Traditional Chinese, and Caribbean folk medicine — most consistently as a remedy for high blood sugar and diabetes. — the fuller story is told in the dedicated History & Traditional Use article.
Active Compounds
Bitter melon contains a complex mix of bioactive constituents:
- Charantin — a sterol glucoside mixture (sitosteryl glucoside and stigmasteryl glucoside) from the fruit that lowers blood sugar, though only at doses too high to account for all of the plant extract’s activity (Raman and Lau, 1996)
- Polypeptide-p (p-insulin) — an insulin-like protein with a minimum molecular weight of about 11,000, roughly 166 amino acids (Khanna and colleagues, 1981), that lowered blood sugar when injected under the skin (subcutaneously) in gerbils, langurs and humans; whether it works when swallowed is questionable (Raman and Lau, 1996)
- Vicine — a pyrimidine nucleoside found in the seeds; it lowers blood sugar only at doses too high to account for all of the extract’s activity (Raman and Lau, 1996), and it can cause hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Momordicins and momordicosides — triterpenoid compounds with anti-inflammatory and antitumor activity
- Cucurbitacins — bitter triterpenoids responsible for the characteristic flavor and contributing to anti-inflammatory effects
- Conjugated linolenic acids — in the seeds, with PPAR-activating activity that improves lipid metabolism
Blood Sugar Regulation
Bitter melon's antidiabetic action operates through multiple complementary mechanisms, more diverse than any single pharmaceutical drug:
- Increased glucose uptake by skeletal muscle through enhanced GLUT4 transporter translocation
- Improved insulin secretion from pancreatic beta cells
- Inhibition of intestinal glucose absorption through suppression of disaccharidase enzymes
- Reduction of hepatic gluconeogenesis (the liver's production of new glucose)
- Direct insulin-like activity from polypeptide-p (shown on injection; its activity when swallowed is questionable)
- Improvement of insulin receptor sensitivity via AMP-activated protein kinase (AMPK) pathway activation
Clinical trials have produced mixed but generally positive results. A 2024 meta-analysis of eight randomized controlled trials in 423 people with type 2 diabetes (Zhang and colleagues) found modest but statistically significant reductions in fasting glucose and hemoglobin A1c (HbA1c), with hemoglobin A1c falling by about 0.38 percentage points. Effects are smaller than those of berberine or pharmaceutical metformin; bitter melon is also an everyday vegetable.
Lipid Metabolism and Body Composition
Beyond glucose, bitter melon has been studied for several markers of metabolic health. Animal studies have shown reductions in total cholesterol, low-density lipoprotein (LDL), and triglycerides, along with increases in high-density lipoprotein (HDL). In people the picture is narrower: the 2024 meta-analysis of eight randomized trials in people with type 2 diabetes (Zhang and colleagues) found total cholesterol fell by 0.38 mmol/L but no significant change in triglycerides, HDL or LDL, and a 2023 meta-analysis of nine randomized trials (Laczkó-Zöld and colleagues) found no significant effect on HDL, LDL or total cholesterol. The seed-derived conjugated linolenic acids appear to activate PPAR-alpha and PPAR-gamma receptors, which regulate fatty acid metabolism and adipocyte differentiation.
In overweight and obese individuals with insulin resistance, bitter melon supplementation has been shown to reduce visceral adipose tissue and improve waist-to-hip ratio when combined with caloric restriction, although the magnitude of effect is modest.
Antimicrobial and Antiviral Activity
Bitter melon has demonstrated activity against a range of bacterial, viral, and parasitic pathogens in laboratory studies. The MAP30 protein isolated from bitter melon seeds has been studied for activity against herpes simplex virus and human immunodeficiency virus (HIV) in cell culture. Traditional use for intestinal parasites, malaria, and dysentery may have a basis in cucurbitacin and momordicin antimicrobial effects.
Clinical evidence in human infectious disease is limited; the antimicrobial findings come from laboratory studies. Integrative practitioners describe it as an adjunct in chronic dysbiosis and as part of broader protocols.
Culinary Preparation
Bitter melon is most commonly consumed as food in Asia. Traditional preparation reduces but does not eliminate the bitterness:
- Slice lengthwise, scoop out the spongy core and seeds, then cut crosswise into thin half-moons
- Salt heavily and let stand for 15-30 minutes to draw out bitter juices, then rinse
- Stir-fry with eggs, garlic, and fermented black beans (Cantonese style)
- Stuff with spiced ground meat (Filipino ampalaya rellena, Indian bharva karela)
- Add to vegetable curries with turmeric, cumin, and coriander
- Juice raw fruit and dilute (intensely bitter; an acquired taste)
- Brew dried slices as cerasee tea (Caribbean tradition)
Doses used for diabetes generally exceed what most people eat as food; the early clinical trials used bitter melon juice, fruit and dried powder (Basch and colleagues, 2003). Supplementation with standardized capsules is the practical option for clinical use.
Forms and Preparations
- Fresh juice — 50-100 mL daily on empty stomach (intensely bitter; often mixed with cucumber or apple to improve the taste)
- Dried fruit powder — 3-5 g daily in capsules or mixed into beverages
- Standardized extract — typically standardized to charantin content (often 7%) at 500-1000 mg twice daily
- Bitter melon seed oil — richer in conjugated linolenic acids; less commonly used clinically
- Whole dried fruit slices — brewed as tea, 3-6 g of dried slices simmered in water for 10-15 minutes
Dosage
Amounts commonly described for bitter melon:
- For type 2 diabetes / blood sugar — 1,000-2,000 mg of standardized extract daily, divided into two or three doses with meals
- Fresh juice — 50 mL twice daily on empty stomach for diabetic patients
- Dietary intake — 100-200 g of cooked bitter melon, two to four times per week
- Duration — effects build over four to eight weeks; hemoglobin A1c reductions are most evident at three months
Cautions and Contraindications
- Pregnancy — bitter melon has been used traditionally to bring on abortion (as an abortifacient) and has uterine-stimulating activity; in animals its main toxicity is to the liver and the reproductive system, effects not reported in humans despite its wide use as a medicine and vegetable (Raman and Lau, 1996)
- Glucose-6-phosphate dehydrogenase deficiency — the seeds contain vicine, which can trigger hemolysis (favism) in individuals with glucose-6-phosphate dehydrogenase deficiency; a favism-like syndrome has been reported with bitter melon (Basch and colleagues, 2003)
- Hypoglycemia risk — bitter melon may add to the effect of other glucose-lowering medicines (Basch and colleagues, 2003) such as insulin, sulfonylureas and metformin, which can push blood sugar too low (hypoglycemia)
- Gastrointestinal upset — bitter melon can cause nausea, abdominal pain, and diarrhea in sensitive individuals, particularly at higher doses or as fresh juice
- Children — coma from low blood sugar (hypoglycemic coma) and convulsions have been reported in children (Basch and colleagues, 2003); the red ripe fruit and seeds have caused vomiting, diarrhea, and hypoglycemic coma in young children
- Fertility — reduced fertility has been reported in mice (Basch and colleagues, 2003)
Key Research Papers
- Khanna P, Jain SC, Panagariya A, Dixit VP. Hypoglycemic activity of polypeptide-p from a plant source. Journal of Natural Products. 1981;44(6):648–655. — PubMed PMID: 7334382
- Raman A, Lau C. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine. 1996;2(4):349–362. — PubMed PMID: 23194773
- Zhang X, Zhao Y, Song Y, Miao M. Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials. Heliyon. 2024;10(10):e31126. — PubMed PMID: 38784554
- Laczkó-Zöld E, Csupor-Löffler B, Kolcsár EB, et al. The metabolic effect of Momordica charantia cannot be determined based on the available clinical evidence: a systematic review and meta-analysis of randomized clinical trials. Frontiers in Nutrition. 2023;10:1200801. — PubMed PMID: 38274207
- Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. American Journal of Health-System Pharmacy. 2003;60(4):356–359. — PubMed PMID: 12625217
PubMed Topic Searches
The following PubMed search links provide curated entry points into the published clinical and mechanistic literature on Bitter Melon (Momordica charantia). Each link opens directly in PubMed at the National Library of Medicine.
- Bitter melon for type 2 diabetes glycemic control — PubMed: Momordica charantia diabetes
- Bitter melon and insulin resistance — PubMed: Momordica insulin resistance
- Bitter melon active compounds: charantin, vicine, polypeptide-p — PubMed: Momordica charantin polypeptide-p
- Bitter melon and cholesterol / triglycerides — PubMed: Momordica lipid cholesterol
- Bitter melon antiviral activity — PubMed: Momordica antiviral
- Bitter melon and cancer cell apoptosis — PubMed: Momordica charantia cancer apoptosis
- Safety and adverse effects of bitter melon — PubMed: Momordica safety
External Authoritative Resources
- NCCIH — Herbs at a Glance
- MedlinePlus — Herbs and Supplements
- PubMed — All research on Momordica charantia
Conditions Bitter Melon Is Used For
Each condition below links to its page. The coloured half of every capsule shows how much human evidence supports this herb for that specific use — traditional use is history, not proof, and is marked as such.
Connections
- All Herbs
- Bitter Melon Benefits Deep Dive
- Berberine
- Gymnema
- Fenugreek
- Cinnamon
- Hemoglobin A1C
- Fasting Insulin
- Lipid Panel
- Blood Sugar
- Diabetes
- Insulin Resistance
- Fasting
- Cancer
- Malaria
- Chanca Piedra for Blood Sugar
- Blood Sugar Remedies — the full index of herbs, nutrients, foods and practices that act on blood glucose
Featured Videos